Minfeng Shu

机构：Shanghai Medical College of Fudan University, Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0003-0514-1892

发表论文 39 篇 · 总被引 1283 次 · h-index 21

代表论文

• Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11 (2021 · Journal of Cellular and Molecular Medicine · 被引 165)
• Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma (2024 · Nature Communications · 被引 67)
• Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer (2022 · Cancer Letters · 被引 55)
• NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion (2024 · Proceedings of the National Academy of Sciences · 被引 52)
• Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia (2015 · Proceedings of the National Academy of Sciences · 被引 33)
• METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC (2021 · Biochemical and Biophysical Research Communications · 被引 30)